À retenir
Across 26 studies (14,739 participants, 3523 with obesity), children and adolescents with obesity consistently spent less than the recommended 60 min/day in moderate-to-vigorous activity (MVPA), and somewhat less than non-obese peers. Studies differed too much to pool, so the review is narrative, and sedentary time showed no marked difference between groups.
Study design
Revue des preuves
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Obesity is thought to go with less activity and more sitting, but how far young people with obesity fall short of recommendations was unclear. The authors reviewed accelerometer studies to compare their MVPA and sedentary time with the guideline and with non-obese peers.
Population et méthode
Systematic review of Medline, Cochrane library, EMBASE, SPORTDiscus and CINAHL from 2000 to 2015, registered on PROSPERO (CRD42015026882). Eligible studies used accelerometers for at least 3 days and 6 h/day in free-living obese children and adolescents aged 0 to 19 years. Study quality was assessed formally. Meta-analyses were planned but precluded by heterogeneity, so results were synthesized narratively.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Of 1503 records, 26 studies were eligible (n = 14,739 participants; n = 3523 with obesity); 6 involved children aged 0 to 9 years and 18 involved adolescents aged 10.1 to 19 years.
- 2Young people with obesity consistently spent less than the recommended 60 min/day in MVPA, and sedentary time was generally high, whatever their age or gender.
- 3Compared with controls, MVPA was significantly lower in children and adolescents with obesity, but the differences were relatively small.
- 4Both groups were consistently below the MVPA recommendation, and there were no marked differences in sedentary time between obese and non-obese peers.
Limites et incertitude
- 1High heterogeneity ruled out meta-analysis, so the review gives no pooled estimate or confidence interval for the gap in MVPA.
- 2Most studies (18 of 26) were in adolescents and only 6 in children aged 0 to 9, so conclusions are less certain for younger children.
- 3Accelerometers differ in cut-points and processing, which the abstract does not detail but which could make studies hard to compare.
- 4The search ended in 2015, and this reading is based on the abstract only.
Mise en perspective
Many young people, with or without obesity, fall short of 60 minutes of MVPA a day, and those with obesity fall short somewhat more. The authors conclude that obesity treatment will need substantial effort to raise activity. Plans for a child's weight or activity should be made with their clinician.
Vos données
Activity trackers on children can show daily active minutes, but their intensity cut-offs differ from research accelerometers. Compare a child's week-to-week trend on the same device, and focus on gradual increases in active minutes rather than a single day's total.
Comprendre ce type de preuve
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
Obesity has been hypothesized to be associated with reduced moderate-to-vigorous physical activity (MVPA) and increased sedentary time (ST). It is important to assess whether, and the extent to which, levels of MVPA and ST are suboptimal among children and adolescents with obesity. The primary objective of this study was to examine accelerometer-measured time spent in MVPA and ST of children and adolescents with obesity, compared with MVPA recommendations, and with non-obese peers.
Methods
An extensive search was carried out in Medline, Cochrane library, EMBASE, SPORTDiscus, and CINAHL, from 2000 to 2015. Study selection and appraisal: studies with accelerometer-measured MVPA and/or ST (at least 3 days and 6 h/day) in free-living obese children and adolescents (0 to 19 years) were included. Study quality was assessed formally. Meta-analyses were planned for all outcomes but were precluded due to the high levels of heterogeneity across studies. Therefore, narrative syntheses were employed for all the outcomes.
Results
Out of 1503 records, 26 studies were eligible (n = 14,739 participants; n = 3523 with obesity); 6/26 studies involved children aged 0 to 9 years and 18/26 involved adolescents aged 10.1 to19 years. In the participants with obesity, the time spent in MVPA was consistently below the recommended 60 min/day and ST was generally high regardless of the participant's age and gender. Comparison with controls suggested that the time spent in MVPA was significantly lower in children and adolescents with obesity, though differences were relatively small. Levels of MVPA in the obese and non-obese were consistently below recommendations. There were no marked differences in ST between obese and non-obese peers.
Conclusions
MVPA in children and adolescents with obesity tends to be well below international recommendations. Substantial effort is likely to be required to achieve the recommended levels of MVPA among obese individuals in obesity treatment interventions. This systematic review has been registered on PROSPERO (International Database of Prospective Register Systematic Reviews; registration number CRD42015026882).
Sources et attribution
Comparison of accelerometer measured levels of physical activity and sedentary time between obese and non-obese children and adolescents: a systematic review.
Elmesmari R, Martin A, Reilly JJ, Paton JY.
BMC pediatrics · 2018-03-09
DOI: 10.1186/s12887-018-1031-0 ↗PubMed · 29523101 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Activity–stroke and heart attack curves differ by accelerometer processing method
Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.
Preventive Medicine
Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven
A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.
Forensic Science International
Activity trackers: about 1,800 more steps a day, but small effects on other outcomes
An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.
The Lancet Digital Health
Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
Sleep

